Extraordinary General Shareholders’ Meeting 2022
Dear Shareholders,
The Extraordinary General Shareholders’ Meeting of Epigenomics AG took place on October 21, 2022 as a virtual event without the physical presence of the shareholders in Munich. The presence amounted to around 26% of the share capital.
Voting results of the Extraordinary General Shareholders’ Meeting 2022 (German only) | |
Invitation to the Extraordinary General Shareholders’ Meeting 2022 of Epigenomics AG | |
Adjusted proposed resolutions (incl. display of amendments, German only) | |
Adjusted proposed resolutions (without display of amendments, German only) | |
Registration form (online with first shipping date) | |
Shareholder Portal | LINK |
Annual Report 2021 (incl. Consolidated Financial Statements, Group Management Report, Supervisory Board Report, Key features of the internal control and risk management system and Remuneration Report) |
|
Financial Statements 2021 (German HGB) incl. key features of the internal control and risk management system (German only) |
|
Balance Sheet of Epigenomics AG (German HGB) as of August 31, 2022 (German only) | |
Questions and answers eSM 2022 Please enter your shareholder number. |
|
Information on data protection | |
Information pursuant to section 125 (2) of the German Stock Corporation Act (AktG) in conjunction with section 125 (5), Article 4 (1) and Table 3 of the Annex to the Commission Implementing Regulation (EU) 2018/1212 (EU-IR) (German only) |
Corporate Governance/Declaration of Governance
2021 | |
Declaration of Compliance with the German Corporate Governance Code pursuant to Section 161 of the German Stock Corporation Act (AktG) – October 2021 | |
Declaration of Governance and reporting on Corporate Governance pursuant to Section 289a German Commercial Code (HGB) |
Further information
Explanation of Shareholders’ rights | |
Articles of Association |